SCHEMBL6880149

SCHEMBL6880149

Cc1cc(C)c(-c2ccccc2)cc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.62
ESR2 Q92731 3/20 0.59
ALDH1A1 P00352 3/20 0.56
HPGD P15428 2/20 0.56
HSD17B10 Q99714 2/20 0.56
ALOX15 P16050 2/20 0.56
MAPK1 P28482 2/20 0.56
KDM4E B2RXH2 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
MAPT P10636 1/20 0.56
G6PD P11413 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
ALOX12 P18054 1/20 0.56
CYP2C19 P33261 1/20 0.56
CCR6 P51684 1/20 0.56
HIF1A Q16665 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374411 0.91 ESR2 (0.59) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL26346234 0.89 BACE1 (0.65) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL4274407 0.89 BACE1 (0.73) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL22888341 0.84 BACE1 (0.65) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL25677023 0.84 BACE1 (0.54) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL5547251 0.84 ESR2 (0.58) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL18311386 0.82 BACE1 (0.56) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL4830408 0.81 ESR2 (0.60) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL27831283 0.80 ESR2 (0.56) BACE1ESR2ALDH1A1HPGDHSD17B10
SCHEMBL28600188 0.79 BACE1 (0.52) BACE1ESR2ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6753451-B2 REACTING KETO COMPOUND, 1,3-DIOXOLANE, AND AN AMMONIUM HALIDE TO YIELD A B-AMINOKETONE; REACTING WITH N-ACETYLMETHYLPYRIDINIUM HALIDE; FRIEDEL-CRAFTS ALKYLATION CIBA SPECIALTY CHEMICALS CORPORATION 2004-06-22 US disclosed
US-20030191349-A1 Process for the preparation of phenylphenol compounds CIBA SPECIALTY CHEMICALS CORP. 2003-10-09 US disclosed
EP-1313689-A1 PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS Ciba SC Holding AG (CH) 2003-05-28 EP disclosed
WO-2002018311-A1 PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-03-07 WO disclosed
EP-0852486-A2 ANTIPLAQUE ORAL COMPOSITION Colgate-Palmolive Company (US) 1998-07-15 EP disclosed
US-5723500-A WATER INSOLUBLE, NONCATIONIC, ANTIBACTERIAL, STERICALLY HINDERED PHENOL; MOUTHWASHES, DENTIFRICES COLGATE-PALMOLIVE COMPANY (US) 1998-03-03 US disclosed
WO-1997010800-A2 ANTIPLAQUE ORAL COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 1997-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191349-A1 Process for the preparation of phenylphenol compounds PAH, CYP1A1, CYP2D6 BACE1 4644/4885ESR2 1769/4885ALDH1A1 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.